Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice

Journal of Experimental Medicine

Volumn 185, Issue 4, 1997, Pages 755-766

  Peters, Malte ^a   Schirmacher, Peter ^a   Goldschmitt, Jutta ^a   Odenthal, Margarete ^a   Peschel, Christian ^a   Fattori, Elena ^b   Ciliberto, Gennaro ^b   Dienes, Hans Peter ^c   Meyer Zum Büschenfelde, Karl Hermann ^a   Rose John, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Inst Ric Biol Molec PA   (Italy)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; BONE MARROW CELL; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL GROWTH; CELL SELECTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; EXTRAMEDULLARY HEMATOPOIESIS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; BODY WEIGHT; CELL DIFFERENTIATION; CELL DIVISION; CELL SEPARATION; CYTOKINE RECEPTOR GP130; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; ORGAN SIZE; SIGNAL TRANSDUCTION; SPLEEN;

EID: 18244419398     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.4.755     Document Type: Article

References (52)

1. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1-78.
2. Bauer, J., and F. Herrmann. 1991. Interleukin-6 in clinical medicine. Ann. Hematol. 62:203-210.
3. Gauldie, J., C. Richards, D. Harnish, P. Lansdorp, and H. Baumann. 1987. Interferon beta 2/B-cell stimulating factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase response in liver cells. Proc. Natl. Acad. Sci. USA. 84:7251-7255.
4. Hibi, M., K. Nakajima, and T. Hirano. 1996. IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med. 74:1-12.
5. Pennica, D., K.L. King, K.J. Shaw, E. Luis, J. Rullamas, S.-M. Luoh, W.C. Darbonne, D.S. Knutzon, R. Yen, K.R. Chien et al. 1995. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA. 92:1142-1146.
6. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell. 76:253-262.
7. Ihle, J.N. 1995. Cytokine receptor signalling. Nature (Lond.). 377:591-594.
8. Schindler, C., and J.E. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
9. Pennica, D., V. Arce, T.A. Swanson, R. Vejsada, R.A. Pollock, M. Armanini, K. Dudley, H.S. Phillips, A. Rosenthal, A.C. Kato, and C.E. Henderson. 1996. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron. 17:63-74.
10. Mosley, B., C. Delmus, D. Friend, N. Boiani, B. Thoma, L.S. Park, and D. Cosman. 1996. Dual Oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271:32635-32643.
11. Maliszewski, C.R., T.A. Sato, T. Vanden Bos, S. Waugh, S.K. Dower, J. Slack, M.P. Beckmann, and K.H. Grabstein. 1990. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1-and IL-4-induced B cell activities in vitro. J. Immunol. 144:3028-3033.
12. Aderka, D., H. Engelmann, V. Hornik, Y. Skornik, Y. Levo, D. Wallach, and G. Kushtai. 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51:5602-5607.
13. Layton, M.J., B.A. Cross, D. Metcalf, L.D. Ward, R.J. Simpson, and N.A. Nicola. 1992. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc. Natl. Acad. Sci. USA. 89:8616-8629.
14. Rose-John, S., and P.C. Heinrich. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:281-290.
15. Baumann, H., Y. Wang, K.K. Morella, C.-F. Lai, H. Dams, D.J. Hilton, R.G. Hawley, and A. Mackiewicz. 1996. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J. Immunol. 157: 284-290.
16. Yamasaki, K., T. Taga, Y. Hirata, H. Yawata, Y. Kawanishi, B. Seed, T. Taniguchi, T. Hirano, and T. Kishimoto. 1988. Cloning and expression of the human interleukin-6 (BSF-2/ IFN β2) receptor. Science (Wash. DC). 241:825-828.
17. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:573-581.
18. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T. Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1149-1157.
19. Müllberg, J., H. Schooltink, T. Stoyan, M. Günther, L. Graeve, G. Buse, A. Mackiewicz, P.C. Heinrich, and S. Rose-John. 1993. The soluble interleukin-6-receptor is generated by shedding. Eur. J. Immunol. 23:473-480.
20. Müllberg, J., E. Dittrich, L. Graeve, C. Gerhartz, K. Yasukawa, T. Taga, T. Kishimoto, P.C. Heinrich, and S. Rose-John. 1993. Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 332:174-178.
21. Novick, D., H. Engelmann, D. Wallach, and M. Rubinstein. 1989. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170:1409-1414.
22. Narazaki, M., K. Yasukawa, K. Saito, Y. Ohsug, H. Fukui, Y. Koishihara, G.D. Yancopoulos, T. Taga, and T. Kishimoto. 1993. Soluble forms of the interleukin-6 signal transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 82:1120-1126.
23. De Benedetti, F., M. Massa, P. Pignatti, S. Albani, D. Novick, and A. Martini. 1994. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J. Clin. Invest. 93:2114-2119.
24. Walev, I., P. Vollmer, M. Palmer, S. Bhakdi, and S. Rose-John. 1996. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 93:7882-7887.
25. Peters, M., S. Jacobs, M. Ehlers, P. Vollmer, J. Müllberg, E. Wolf, G. Brem, K.-H. Meyer zum Büschenfelde, and S. Rose-John. 1996. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1399-1406.
26. Fattori, E., C. Della Rocca, P. Costa, M. Giorgio, B. Dente, D. Pozzi, and G. Ciliberto. 1994. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood. 83:2570-2579.
27. - double-negative lymphocytes in autoimmune MRL-lpr/lpr mice. J. Exp. Med. 172:7-12.
28. Peschel, C., W.E. Paul, J. Ohara, and I. Green. 1987. Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood. 70:254-263.
29. Yoshida, K., T. Taga, M. Saito, S. Suematsu, A. Kumanogh, T. Tanaka, H. Fujiwara, M. Hirata, T. Yamagami, T. Nakahata, and T. Kishimoto. 1996. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, lead to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:407-411.
30. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Köhler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (Lond.). 368:339-342.
31. Bernad, A., M. Kopf, R. Kulbacki, N. Weich, G. Köhler, and J.C. Guttierrez-Ramos. 1994. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity. 1:725-731.
32. Shen, M.M., R.C. Skoda, R.D. Cardiff, J. Campos-Torres, P. Leder, and D.M. Ornitz. 1994. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO (Eur. Mol. Biol. Org.) J. 13:1375-1385.
33. Malik, N., H.S. Haugen, B. Modrell, M. Shoyab, and C.H. Clegg. 1995. Developmental abnormalities in mice transgenic for bovine Oncostatin M. Mol. Cell. Biol. 15:2349-2358.
34. Ware, C.B., M.C. Horowitz, B.R. Renshaw, J.S. Hunt, D. Liggit, S.A. Kobler, B.C. Gliniak, H.J. McKenna, T. Papayannopoulou, B. Thoma et al. 1995. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 121:1283-1299.
35. Taga, T., Y. Kawanishi, R. Hardy, T. Hirano, and T. Kishimoto. 1987. Receptors for B cell stimulatory factor 2. Quantification, specificity, distribution and regulation of their expression. J. Exp. Med. 166:967-981.
36. Suematsu, S., T. Matsuda, K. Aozasa, S. Akira, N. Nakano, S. Ohno, J.-I. Miyazaki, K.-I. Yamamura, T. Hirano, and T. Kishimoto. 1989. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA. 86:7547-7551.
37. Suematsu, S., T. Matsusaka, T. Matsuda, S. Ohno, J.-I. Miyazaki, K.-I. Yamamura, T. Hirano, and T. Kishimoto. 1992. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA. 89:232-235.
38. Tartaglia, L.A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G.J. Richards, S.A. Campfield, F.T. Clark, J. Deeds et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1263-1271.
39. Baumann, H., K.K. Morella, D.W. White, M. Dembski, P.S. Bailon, H. Kim, C.-F. Lai, and L.A. Tartaglia. 1996. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA. 93:8374-8378.
40. Vaisse, C., J.L. Halaas, C.M. Horvarth, J.E. Darnell, M. Stoffel, and J.M. Friedman. 1996. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Gen. 5:765-768.
41. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nat. (Lond.). 372: 425-431.
42. Taniguchi, H., T. Toyoshima, K. Fukao, and H. Nakauchi. 1996. Presence of hematopoietic stem cells in the adult liver. Nature Med. 2:198-203.
43. Sui, X., K. Kohichiro, R. Tanaka, S. Tajima, K. Muraoka, Y. Ebihara, K. Ikebuchi, K. Yasukawa, T. Taga, T. Kishimoto, and T. Nakahata. 1995. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA. 92:2859-2863.
44. Rose-John, S., H. Schooltink, D. Len, E. Hipp, G. Dorfheus, H. Schmitz, X. Schiel, T. Hirano, T. Kishimoto, and P.C. Heinrich. 1990. Studies on the structure and regulation of the human hepatic interleukin-6-receptor. Eur J. Biochem. 190: 79-83.
45. Hirota, H., K. Yoshida, T. Kishimoto, and T. Taga. 1995. Continuous activation of gp130, a signal-transducing receptor component for interleukin-6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA. 92:4862-4866.
46. Fukushima, N., H. Nishim, Y. Koishihara, and H. Ohkawa. 1992. Enhanced hematopoiesis in vivo and in vitro by splenic stromal cells derived from the mouse with recombinant granulocyte colony-stimulating factor. Blood. 80:1914-1922.
47. Metcalf, D., and D.P. Gearing. 1989. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA. 86:5948-5952.
48. Escary, J.L., J. Perreau, D. Duménil, S. Ezine, and P. Brûlet. 1993. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature (Lond.). 363:361-364.
49. Flanagan, J.G., and P. Leder. 1990. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 63: 195-194.
50. Zsebo., K.M., D.A. Williams, E.N. Geissler, V.C. Broudy, F.H. Martin, H.L. Atkins, R.Y. Hsu, N.C. Birkett, K.H. Otkino, and D.C. Murdock. 1990. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 63:213-224.
51. Nagasawa, T., S. Hirota, K. Tachibana, N. Takakura, S.-I. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikitani, and T. Kishimoto. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature (Lond.). 382:635-638.
52. Hunte, B.E., S. Hudak, D. Campbell, Y. Xu, and D. Rennick. 1995. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J. Immunol. 156:489-496.